Peptide deformylation is an essential process in eubacteria. The peptide deformylase Def has been suggested to be an attractive target for antibacterial drug discovery. Some eubacteria including medically important pathogens possess two def-like genes. Until now, the functionality of both genes has been tested only in Staphylococcus aureus with the result that one gene copy was functional. Here, expression of two functional def-like gene products in Bacillus subtilis is demonstrated. Besides the def gene, which is chromosomally located close to the formyltransferase gene fmt and which was overexpressed and biochemically tested previously, B. subtilis possesses a second def-like gene, called ykrB. The encoded protein is 32 % identical to the def gene product. It was shown that either def or ykrB had to be present for growth of B. subtilis in rich medium (each was individually dispensable). Studies with a def/ykrB double deletion strain with xylose-inducible ykrB copy demonstrated that, besides def, the gene ykrB is a second cellular target of deformylase inhibitors such as the antibiotic actinonin. The gene products exhibited similar enzymic properties, exemplified by similar inhibition efficacy of actinonin in biochemical assays. Antibiotic susceptibility tests with different deletion strains and Northern analyses indicated that YkrB is probably the predominant deformylase in B. subtilis. It was shown that duplication of the deformylase function does not lead to an increased actinonin-resistance frequency in comparison to B. subtilis mutants carrying only one deformylase gene.
INTRODUCTION
In eubacteria, nascent polypeptide chains carry Nformylmethionine as the first amino acid, and this is removed during protein maturation by the action of two enzymes : the peptide deformylase (Def) and the methionine aminopeptidase (Map) (Adams, 1968 ; Sherman et al., 1985) . The deformylation is a requirement for the activity of Map (Solbiati et al., 1999) and probably therefore an essential process in eubacteria, as shown in Escherichia coli (Mazel et al., 1994 ; Meinnel & Blanquet, 1994) and Staphylococcus aureus (Margolis et 50 , inhibitor concentration which inhibits 50 % of enzyme activity ; K i , dissociation constant ; K m , Michaelis constant ; MAS, methionine-alanine-serine ; MLS, macrolide/lincosamide/streptogramin.
Abbreviations : fMAS, N-formylmethionine-alanine-serine ; IC

al., 2000)
. Only when the N-formyltransferase (Fmt), catalysing the formylation of the initiator methionyl tRNA (tRNA fMet ), is inactivated does the def gene seem to be non-essential for bacterial survival and can be deleted (Mazel et al., 1994) .
Formylated proteins exist not only in eubacteria, but also in mitochondria and plastids (Kozak, 1983) ; various plant mitochondria and chloroplasts possess Def activity (Braun & Schmitz, 1993 ; Shanklin et al., 1995) but it has not been detected in mammalian mitochondria (for a review see Giglione et al., 2000) .
The def gene was first isolated from E. coli (Meinnel & Blanquet, 1993 ; Mazel et al., 1994) . Subsequently, several other def genes from Gram-negative and Grampositive bacteria have been characterized on the genetic and\or biochemical level (Meinnel & Blanquet, 1994 ; Fig. 1 . Multiple sequence alignment of the predicted catalytic domains of peptide deformylases. Class II deformylases : YKRBIBACSU (YkrB from B. subtilis, SWISS-PROT accession no. Q45495) ; DEF (inactive)ISAU [inactive Def variant translated from the genomic sequence of S. aureus NCTC 8325 generated at the Oklahoma University (Oklahoma City, OK, USA)] ; DEFIBACST (Def from B. stearothermophilus, SWISS-PROT accession no. O31410) ; DEFISAU (Def from S. aureus, Genpept accession no. AAG02249). Class I deformylases : DEFIBACSU (Def from B. subtilis, SWISS-PROT accession no. P94462) ; DEFIECOLI (Def from E. coli, SWISS-PROT accession no. P27251). Three conserved motifs defining the catalytic domain are shown. Bold amino acid residues deviate from the conserved motifs (Meinnel et al., 1997) . The positions of the motifs in protein YKRBIBACSU are : motif 1, G58-Q65 ; motif 2, E108-S112 ; motif 3, Q152-G160. Along the complete amino acid sequence, YKRBIBACSU exhibits identities of 67 % to DEFIBACST, 61 % to DEFISAU, 32 % to DEFIBACSU, 30 % to DEF (inactive)ISAU and 27 % to DEFIECOLI. Mazel et al., 1997 ; Meinnel et al., 1997 ; Belouski et al., 1998 ; Evans et al., 1998 ; Huntington et al., 2000 ; Chen et al., 2000) . Def homologues have been identified in all eubacteria, but not in Archaea, Saccharomyces cerevisiae and Caenorhabditis elegans. They can also be found in eukaryotic parasites such as Plasmodium falciparum and Trypanosoma spp. (Meinnel, 2000) , in higher plants such as Arabidopsis thaliana (Genpept accession no. CAB87633), in Drosophila melanogaster (Genpept accession no. AAF54540), as well as in mice and humans (GenBank accession nos BE303602 and AW499510), although their exact function, especially in the fruit fly and in mammals, is unknown. In conclusion, the Def protein, which is essential for bacterial but probably not for mammalian survival, is broadly conserved among living organisms. Thus Def has been suggested to be an attractive target for antibacterial (and eventually antiparasitic) drug discovery (Giglione et al., 2000 ; Meinnel, 2000) .
Indeed, a potent peptide deformylase inhibitor with antibacterial activity has recently been identified . Actinonin is active against both Grampositive and Gram-negative bacteria, indicating a high degree of similarity among eubacterial deformylases. Based on amino acid sequence similarity, peptide deformylases can be divided into two subfamilies (Giglione et al., 2000) . One is represented by the E. coli enzyme and many deformylases from Gram-negative bacteria (class I) and the second by enzymes from Bacillus stearothermophilus and many Gram-positive bacteria (class II). Meinnel et al. (1997) have already reported that B. stearothermophilus and E. coli peptide deformylases share close enzymic properties in spite of little sequence homology. Some eubacteria possess two def genes, especially Grampositive representatives. Recently, it was shown that in S. aureus only one of the two genes is responsible for peptide deformylation (Margolis et al., 2000) . In Bacillus subtilis, a def class I gene was cloned previously and shown to encode a functional peptide deformylase (Mazel et al., 1997 ; Leiting et al., 1998 ; Durand et al., 1999 ; Huntington et al., 2000) . On the other hand, B. subtilis contains an additional deformylase-like gene, called ykrB, whose product is highly similar to the class II deformylase from B. stearothermophilus (Fig. 1) . We therefore investigated whether this gene is also functional in B. subtilis. Here, we present data that B. subtilis harbours two functional peptide deformylases, in contrast to all other eubacteria studied so far. This is the first time that the biochemical and physiological roles of two functional Def proteins derived from one organism are compared.
METHODS
Materials, bacterial strains, growth conditions and plasmids.
Actinonin, lysozyme, xylose and fluorescamine were purchased from Sigma Aldrich ; N-formylmethionine-alanineserine (fMAS) and methionine-alanine-serine (MAS) were obtained from Bachem ; ciprofloxacin was from Bayer. All other chemicals were of the highest commercial grade.
E. coli XL-1 Blue was used for cloning, and E. coli M15 for IPTG-induced protein overexpression (see Table 1 ). The gene replacement experiments were performed in B. subtilis strain 168, which we call the wild-type strain in our studies. In this work, we generated several B. subtilis deletion strains (see Table 1 ).
All strains were grown in LB medium (1 % Bacto Tryptone, 0n5 % yeast extract, 0n5 % NaCl) with the appropriate selection. For antibiotic selection, the concentrations of antibiotics were 50 µg ampicillin ml − ", 5 µg chloramphenicol ml − ", 20 µg neomycin ml − ", 0n5 µg erythromycin ml − "j12n5 µg lincomycin ml − " [for selecting macrolide\lincosamide\strepto-gramin (MLS) resistance] and 100 µg spectinomycin ml − ". Cell densities (OD '!! ) were recorded with the UV-vis spectrophotometer DU-64 (Beckmann).
To overexpress proteins, the vector pQE60 (Qiagen) was used. The plasmids pJH101 (Ferrari et al., 1983) and pDG1731xyl were used for gene replacement experiments. Plasmid pDG1731xyl is a derivative of pDG1731 (Guerout-Fleury et al., 1996) . A 1485 bp DNA fragment containing the xyloseregulator gene xylR and the xylose-inducible promoter of gene xylA P xylA from Bacillus megaterium was amplified from plasmid pX (Kim et al., 1996) using the primers XYL1 (5h-AGAGGATCCCATTTCCCCCTTTG-3h) and XYL2 (5h-ATCAGATCTATCAACGTGATATAGGTTTGC-3h). The PCR product's terminal BamHI and BglII restriction sites were used to introduce it into the BamHI site of pDG1731, so that genes could be cloned into the one remaining BamHI site downstream of P xylA . Plasmid pBEST501 was used to obtain the neomycin-resistance cassette by restriction digestion with the enzymes XbaI and NotI (Itaya et al., 1989 ). An erythromycin-resistance cassette was obtained from pDG1731 (Guerout-Fleury et al., 1996) by amplification using the primers ERM1 (5h-ATCTCTAGACCCGGGCTTGATCCA-TGGATTACGCG-3h) with a 5h-terminal XbaI site and ERM2 (5h-ATCGCGGCCGCTTACTTATTAAATAATTTATAG- Itaya et al. (1989) * nm, the neomycin-resistance gene ; erm, the erythromycin-resistance gene ; and spc, the spectinomycin-resistance gene.
CTATTG-3h) with a 5h-terminal NotI site, which could be digested with the respective restriction enzymes. A summary of the plasmids used in this study is given in Table 1 .
E. coli and B. subtilis genetics, and PCR protocols. DNA purification, restriction digestion, ligation and transformation of E. coli were performed according to standard protocols (Sambrook et al., 1989) . Genetic techniques with B. subtilis, including transformation procedures, were performed as described by Harwood & Cutting (1990) .
All PCR primers had a calculated melting temperature of approximately 60 mC. For cloning purposes, Pwo DNA polymerase (Roche) was used, and for colony PCR procedures, a mixture of Taq DNA polymerase (Roche) and Thermo Sequenase (Amersham) was used. Flanking regions and genes for cloning into expression vectors were amplified from 100 ng B. subtilis chromosomal DNA at primer concentrations of 1 µM and dNTP concentrations of 250 µM. Twenty-five reaction cycles of 30 s at 94 mC\30 s at 52 mC\1-2 min at 72 mC were carried out followed by a final 5 min incubation at 72 mC.
Complementary 5h-and 3h-flanking regions of PCR products were assembled by mixing 1 µl of each PCR reaction as template for the second PCR with outward primers and under the same conditions as described before. Diagnostic PCR on bacterial colonies was performed as follows. Cell material was suspended in 50 µl H # O. A PCR reaction was performed in 50 µl with 5 µl of the suspended colony and under the same conditions described above.
Deletion experiments in B. subtilis. Deletions of the def and ykrB wild-type loci were generated as follows. The 600 bp regions upstream and downstream of the genes of interest were PCR-amplified using the following oligonucleotide combinations : DEF1A (5h-ATCGGATCCGCTGTTAACG-CAAGTCAGCG-3h)\DEF1B (5h-TGCGGCCGCTAAATCT-AGACTCCGCAGGATGTGTGACGAC-3h) and YKRB1-A(5h-ATCGGATCCTAGCGTCTTTCACGTTAAATCC3h)\YKRB1B (5h-TGCGGCCGCTAAATCTAGACTCGAT-GTTTTCCATAGTAATCAAG-3h) for amplification of the upstream regions, including 11 5h-codons of def and seven 5h-codons of ykrB, respectively, as well as DEF2A (5h-AGTC-TAGATTTAGCGGCCGCAATCTAAAATAAGTAAAT-ACTATACAG-3h)\DEF2B (5h-ATCGGATCCAATTTTTC-TACCATATACATAATGG-3h) and YKRB2A (5h-AGTCT-AGATTTAGCGGCCGCATATTGTGTTTCCTTTCA-AAGAACC-3h)\YKRB2B (5h-ATCGGATCCGTTCTCGA-GGGAATCGGCAG-3h) for amplification of the downstream regions, including seven 3h-codons of def and 17 3h-codons of ykrB, respectively. The primers were designed such that the ends of the PCR products facing the 5h-and 3h-regions of the genes carried a complementary tag sequence (5h-AGTCT-AGATTTAGCGGCCGCA-3h). This tag sequence was used to assemble the products in a second PCR reaction using the outward primers. The outward primers contained terminal BamHI restriction sites allowing cloning of the fusion-PCR product into the BamHI site of pJH101. The sequence cloned into pJH101 internally contained the tag sequence, which could be cut by XbaI and NotI. Using these restriction enzymes, a neomycin-resistance (Nm R ) cassette derived from pBEST501 and an erythromycin-resistance cassette (Em R ) derived from pDG1731 could be integrated, respectively. The resistance cassettes did not include any transcription term-ination sequences and were cloned in the same transcriptional orientation as the deleted genes. The resulting pJH101 derivatives were transformed into B. subtilis 168. The transformants were tested for neomycin or erythromycin resistance and chloramphenicol sensitivity in order to find clones where the deletion marker was introduced into the chromosome by a double homologous recombination event. The clones ' correct genotypes were determined according to the sizes of the PCR products obtained from colony PCRs with appropriate primers flanking the regions of recombination. Correct recombinant clones were tested for their growth rate in LB medium. Ectopic expression of the gene ykrB under the control of the xylose-inducible promoter P xylA was achieved by subcloning the PCR product containing the B. subtilis gene into the expression vector pDG1731xyl [PCR primer pair : YKRBR (5h-ATCGGATCCATGATTACTATGGAAAACATCGTAC3h)\YKRBT (5h-ATCGGATCCTTAGCGCTCAATTGCG-ATTGC-3h)] and subsequent integration at the thrC locus of the B. subtilis def-deletion mutant by marker exchange as described elsewhere (Guerout-Fleury et al., 1996) . The chromosomal integration obtained with pDG1731xyl was marked with the spectinomycin-resistance (Spc R ) determinant. After ectopic integration of ykrB under the control of P xylA , the B. subtilis def-deletion mutant was transformed with a pJH101 derivative in order to delete the ykrB wild-type locus. This time the transformants were selected on selective media containing 0n25 % (w\v) xylose. Clones resistant to spectinomycin (marker of xylose-inducible ykrB copy) and erythromycin (marker for the ykrB wild-type locus deletion), but sensitive to MLS and chloramphenicol (markers for the presence of pDG1731 and pJH101 sequences), were selected. The clones ' correct genotypes were again verified using diagnostic colony PCRs with appropriate primers. A correct recombinant clone was tested for its ability to grow on LB medium without xylose. Ectopic expression of the gene def under the control of the xylose-inducible promoter P xylA was achieved by subcloning the PCR product containing the gene into the expression vector pDG1731xyl [PCR primer pair : DEFR (5h-ATCG-GATCCATGGCAGTAAAAAAGGTCGTCAC-3h)\DEFT (5h-ATCGGATCCTCATCCTTCCATATCCGCTAG-3h)] and subsequent integration at the thrC locus of the B. subtilis def-deletion mutant by marker exchange as described before. The strain obtained served as control for detection of high expression of def in Northern analyses.
RNA preparation and Northern analyses. Total RNA was isolated from B. subtilis with the ' Qiagen RNeasy Mini kit '. Cells were grown in 10 ml LB medium at 37 mC until they reached OD '!!
0n5. An equal volume of ice-cold killing buffer (5 mM MgCl # ; 20 mM NaN $ ; 20 mM Tris\HCl, pH 7n5) was added. The cells were harvested and resuspended in 1 ml lysis buffer (25 %, w\v, saccharose ; 1 mg lysozyme ml − " ; 250 µM EDTA ; 20 mM Tris\HCl, pH 8n0). After incubation on ice for 10 min and centrifugation at 4000 g at 4 mC for 5 min, the pellet was resuspended in 100 µl TE buffer (1 mM EDTA ; 10 mM Tris\HCl, pH 8n0). The following isolation steps were performed according to the manufacturer's instructions. The obtained RNA (100 µg) was dissolved in H # O and stored at k80 mC.
Digoxigenin-labelled RNA probes were produced by run-off transcription with 1 µg PCR product as template using the ' DIG RNA labelling kit ' with digoxigenin-labelled UTP according to the manufacturer's instructions (Roche). The PCR product representing gene def was generated with primers DEFR (see above) and DEFTT7 (5h-CTAATACG-ACTCACTATAGGGAGACATCCTTCCATATCCGCT-AG-3h) ; the product representing ykrB was obtained with primers YKRBR (see above) and YKRBTT7 (5h-CTAATA-CGACTCACTATAGGGAGAGCGCTCAATTGCGATT-GC-3h). The 5h-ends of the 3h-terminal primers contained the promoter of the T7 RNA polymerase (see letters in italics within the primer sequences mentioned before). Total RNA (10 µg) was electrophoresed through formaldehyde gels (Sambrook et al., 1989) . The RNA size standard was obtained from Gibco-BRL. After electrophoresis, RNA was transferred to a GeneScreen Plus nylon membrane (NEN) by capillary transfer using 20i SSC (3 M NaCl, 0n3 M sodium citrate). RNA was then stained with 0n1 % methylene blue. Hybridization and subsequent detection of the RNA probe with CDP-Star as substrate were performed according to ' The Dig System User's Guide for Filter Hybridization ' (Roche). Briefly, the overnight hybridization with 300 ng labelled probe ml − " as well as the four 15 min washing steps (twice in 2i SSC, 0n1 % SDS and twice in 0n1i SSC, 0n1 % SDS) were carried out at 60 mC. The chemiluminescence signals on the membrane were measured in the Lumi Imager F1 (Roche).
Antibiotic susceptibility tests. Microdilution MICs were determined against B. subtilis strains in 96-well microtitre plates in LB medium containing serial dilutions (twofold) of antibiotics. A starting inoculum of 0n5-1n0i10& c.f.u. ml − " derived from exponentially growing cells was used. The MIC was the lowest concentration of drug that yielded no visible growth after incubation for 18-24 h at 37 mC. End points were determined by measuring the OD '!! with the microtitre plate reader EL312e (Bio-Tec Instruments). Growth curves of B. subtilis strains with actinonin treatment were obtained as follows. An overnight culture of B. subtilis was diluted 100-fold into fresh LB medium and grown to OD '!! 0n1. The cell cultures were diluted by 10-fold into 50 ml fresh LB medium and incubated at 37 mC. At OD '!! 0n4 (10) c.f.u. ml − "), actinonin was added to the culture (final concentration 20 µg ml − ") and growth of the B. subtilis strains was continuously monitored spectrophotometrically.
Isolation of actinonin-resistant mutants. Spontaneous actinonin-resistant mutants were isolated by plating approximately 10) c.f.u. from exponentially growing cells of B. subtilis on LB agar plates containing 32 µg actinonin ml − ". The plates were incubated at 37 mC overnight. Colonies that grew were transferred to 5 ml actinonin-free LB medium and grown overnight before again determining the MICs of actinonin for such clones. Using this isolation procedure, the frequency of actinonin-resistant clones was determined.
Cloning, expression and purification of Def and YkrB. The B. subtilis genes def and ykrB were PCR-amplified from genomic DNA of B. subtilis 168 and cloned into expression vector pQE60 (Qiagen) using NcoI and BamHI restriction sites. The oligonucleotide combinations were as follows : DEF1 (5h-GCGCCCATGGCAGTAAAAAAGGTCGTCAC-3h)\DEF2 (5h-GCGCAGATCTTCCTTCCATATCCGCTAG-3h) and YKRB1 (5h-GCGCCCATGGTTACTATGGAAAACATCG-TACG-3h)\YKRB2 (5h-GCGCAGATCTGCGCTCAATTG-CGATTGCATT-3h). The resulting plasmid constructs were confirmed by DNA sequence analysis and used to transform E. coli M15. The M15 strains containing the expression vectors were grown exponentially up to OD '!! 0n5 at 37 mC in LBampicillin-kanamycin medium and then induced with 1 mM IPTG for 4 h before harvesting by centrifugation. The proteins were purified in a single step and under native conditions using nickel-nitrilotriacetic acid columns according to the manu- 
Two peptide deformylases in Bacillus subtilis
facturer's instructions (Qiagen ; QIAexpressionist manual). Subsequently, nickel sulfate was added to a final concentration of 10 mM. Proteins were quantified using BSA as standard (Bradford, 1976) . The purified proteins, which were 95 % pure as estimated by SDS-PAGE, were directly tested in enzymic assays. Enzyme assay. The deformylase activity was measured in 384-well microtitre plates. Twenty microlitres of buffer (50 mM HEPES, pH 7n0 ; 10 mM NaCl ; 0n1 % Triton X-100) was mixed with 20 µl enzyme solution (end concentration in 60 µl assay volume : 450 nM) and incubated for 20 min at room temperature (RT). The reaction was started by addition of appropriate amounts of substrate (fMAS) and incubated for 60 min at RT. The free amino-terminus of the deformylated product MAS was measured by addition of 20 µl fluorescamine solution (2n5 µg ml − " 100 % DMSO). Fluorescence was measured using Spectrafluor Plus (Tecan) with the excitation wavelength at 390 nm and the emission wavelength at 465 nm. To determine product concentrations, standard curves were established by measuring defined concentrations of MAS mixed with fluorescamine solution spectrophotometrically.
RESULTS AND DISCUSSION
B. subtilis contains two def-like genes and one of these has to be present for growth to occur B. subtilis possesses two def-like genes, def and ykrB. We successfully deleted each gene by replacement with neomycin cassettes engineered to enable non-polar insertions. The def-deletion mutant MHD101 as well as the ykrB-deletion mutant MHY101 exhibited growth rates in LB medium identical to that of wild-type B. subtilis (Fig. 2) . Obviously, both genes were each individually non-essential for growth. Subsequently, we 
Fig. 2. Growth of B. subtilis mutants in LB medium
. Growth of the following strains was monitored : B. subtilis wild-type (wt), the def-deletion strain MHD101, the ykrB-deletion strain MHY101, and the def/ykrB double deletion strain MHY103 with xylose-inducible ykrB copy. The wild-type strain and the mutant MHY103 were also grown in the presence of xylose. The experiment was performed as follows. A volume of 5 ml xylosefree LB medium was inoculated with fresh colonies, grown on LB-agar plates with 0n25 % xylose, and incubated overnight at 37 mC. Flasks containing 50 ml LB with and without 0n25 % (w/v) xylose were inoculated with diluted aliquots of the overnight culture (start OD 600 0n01) and incubated at 37 mC. Growth was monitored by optical density measurements. $, MHY103 (LB) ; , MHY103 (LBjxylose) ; W, MHD101 (LB) ; 5, MHY101 (LB) ; =, wt (LB) ; , wt (LBjxylose).
tried to generate a mutant carrying deletions in def as well as in ykrB. We tried to replace the respective second def-like gene with an erythromycin-resistance cassette in both deletion strains MHD101 and MHY101. We were not able to generate such double deletions. After integration of ykrB downstream from a xyloseinducible promoter into the thrC region of the defdeletion strain MHD101, we were able to delete the ykrB wild-type locus. The generated mutant MHY103, which carried deletions in the natural loci of def and ykrB and harboured the xylose-inducible ykrB copy, grew with xylose such as the B. subtilis wild-type, but exhibited a growth arrest over 5 h in xylose-free LB medium under the conditions described in Fig. 2 . Afterwards, we could recover growth of strain MHY103 and harvest cells for RNA preparation (OD '!! 0n5 reached after 10 h), because the xylose-promoter system is leaky (Rygus & Hillen, 1992) . We demonstrated that ykrB transcripts could not be detected in Northern analyses using digoxigenin-labelled probes (see Methods). In contrast, in the presence of 0n25 % xylose a high amount of ykrB transcripts was found in strain MHY103 (Fig. 3) . We can conclude that the function encoded by def and ykrB, which complement each other, is essential for survival of B. subtilis.
Both proteins Def and YkrB catalyse peptide deformylation
The genes def and ykrB were PCR-amplified from genomic DNA of B. subtilis and cloned into the expression vector pQE60. They were overexpressed in E. coli M15 and purified as proteins with C-terminal His ' -tags. The proteins were tested for their peptide deformylase activity (see Methods). In order to keep the activity of the proteins stable, we saturated the enzymes with NiSO % (Giglione et al., 2000) . This treatment did not significantly change the enzymic properties of the originally purified proteins as we have tested this previously (data not shown). We could show that both proteins (Def and YkrB) catalyse the deformylation of fMAS, the substrate which we used in our enzymic deformylase assay (Fig. 4) . The enzymes Def and YkrB exhibited similar apparent Michaelis constants (K m ) for fMAS of 2n3 mM and 3n0 mM, respectively. Under conditions fully saturated with substrate, YkrB was 2n5 times faster than Def (apparent turnover number l 0n17 s −" and 0n07 s −" , respectively). Besides similar K m values, the similarity in enzymic properties could also be demonstrated by the inhibition of their activities in the presence of actinonin. Under the same assay conditions, the actinonin concentrations which could inhibit 50 % of enzyme activity (IC &! ) were 95 nM in the case of Def and 130 nM in the case of YkrB (Fig. 4) .
Def and YkrB possess similar enzymic properties in cellular as well as cell-free systems Chen et al. (2000) have already demonstrated that the expression level of a deformylase in E. coli can be correlated with the antibacterial activity of actinonin, 6) ; def-deletion strain MHD101 (lanes 2 and 7) ; ykrB-deletion strain MHY101 (lanes 3 and 8) ; def/ykrB double deletion strain MHY103 with ectopic, xylose-inducible copy of ykrB grown in the absence (lane 4) and presence (0n25 %, w/v ; lane 5) of xylose ; def-deletion strain MHD104 with ectopic, xylose-inducible copy of def (see Table 1 ) grown in the absence (lane 9) and presence (0n25 %, w/v ; lane 10) of xylose. A digoxigenin-labelled RNA complementary to ykrB was used as hybridization probe from lanes 1 to 5, and a digoxigenin-labelled RNA complementary to def was used as hybridization probe from lanes 6 to 10. Lengths of the RNA size standard are given on the left side ; transcript lengths detected with the hybridization probes are shown on the right side. While a ykrB transcript could be detected [length approx. 0n7 kb, lanes 1 and 2], no clear hybridization signal could be obtained using the def-antisense probe. Ectopic overexpression of ykrB and def after xylose induction could be monitored (lanes 5 and 10). The def-and ykrB-containing transcripts have comparable sizes, because the def gene is only 70 nt shorter than ykrB. The transcripts probably contain only ykrB or def (approx. 0n6 and 0n8 kb) ; ykrB or def and parts of spc (approx. 1n1 and 1n4 kb) ; ykrB or def and complete spc (approx. 1n7 kb) ; ykrB or def, spc and thrC-3h-end (approx. 2n2 kb) ; ykrB or def, spc, thrC-3h-end and thrB [approx. 3n4 kb ; see also part (a)]. . At low xylose concentrations, the actinonin MIC for strain MHY103 was 0n003-0n012 µg ml − 1 , while the MIC of 0n9 µg ml − 1 at high xylose concentrations ( 0n25 %) was only one dilution step (1 : 2) lower than the MIC for the wild-type strain (1n9 µg ml − 1 ). (Fig. 5a ).
At high xylose concentrations ( 0n25 %) no further increase in MIC values could be detected (Fig. 5a) . Similar results were reported by Chen et al. (2000) , who used an E. coli strain with an arabinose-inducible def gene. This plateau in MIC values might indicate that at high inductor concentrations the deformylase activity of the induced protein is no longer proportional to the inductor concentration.
The B. subtilis peptide deformylase Def has already been successfully isolated and tested for deformylase function (Leiting et al., 1998 ; Durand et al., 1999 ; Huntington et al., 2000) . Peptide thiol-like deformylase inhibitors exhibiting a wide range of dissociation constants (K i ) against Def of B. subtilis possessed MIC values for B. subtilis which could be correlated with the K i values of the inhibitors (Huntington et al., 2000) . This is only possible if YkrB is inhibited as efficiently as Def by peptide thiols, since our data demonstrate that def alone is not essential for growth of B. subtilis and ykrB also encodes a functional deformylase. Obviously, the class I and class II deformylases of B. subtilis possess similar enzymic properties in a cellular as well as in a cell-free system.
B. subtilis probably contains more YkrB than Def
When we tested the sensitivity of B. subtilis carrying deletions in either def or ykrB, we found that the ykrBdeletion mutant MHY101 was more sensitive to actinonin than the def-deletion strain MHD101. While the MIC values for MHY101 were 0n3-0n5 µg ml −" , the MIC values of MHD101 correspond to the MIC values for the wild-type strain (1n9 µg ml −" ). When we compared the growth curves of mutants and wild-type strain with actinonin treatment, an increased sensitivity of the ykrB-deletion mutant MHY101 in comparison to the def-deletion strain MHD101 could also be demonstrated (compare strains MHY101jactinonin and MHD101jactinonin in Fig. 5b ). Since Def and YkrB possess similar enzymic properties and are inhibited by actinonin with the same efficiency, the simplest and most probable explanation for the different sensitivity of deletion mutants to actinonin is that B. subtilis contains more YkrB proteins than Def proteins. Thus deletion of ykrB makes B. subtilis more sensitive to actinonin than deletion of def.
Northern analyses support the idea that ykrB is more highly expressed in B. subtilis than def (Fig. 3 ). We were able to detect a monocistronic transcript in B. subtilis wild-type and in the def-deletion strain MHD101, which disappeared in the ykrB-deletion strain MHY101. In contrast, we were not able to clearly identify def transcripts in B. subtilis wild-type and in the ykrBdeletion mutant using digoxigenin-labelled probes, although def-containing transcripts in a strain overexpressing def could be detected using the same probe.
Taking the results of the actinonin sensitivity tests and the Northern analyses together, we can conclude that YkrB is probably the predominant deformylase in B. subtilis, although final experiments on the protein level have to be performed to strengthen this conclusion.
Actinonin resistance of organisms with two deformylases
Besides B. subtilis, there are other organisms including important pathogens such as S. aureus which contain two deformylase genes. In S. aureus, one of the two def copies (the one which is associated with fmt in the chromosome) exhibits deviations in the catalytically important sequence motifs ( Fig. 1) and has been identified to be inactive (Margolis et al., 2000) . In B. subtilis, both Def-like proteins harbour conserved sequence motifs ( Fig. 1) and are indeed functional. Several other pathogens, such as Pseudomonas aeruginosa, Streptococcus pneumoniae and Streptococcus pyogenes, could also possess two functional deformylases (Margolis et al., 2000 ; Giglione et al., 2000) . Redundancy of essential functions in the bacterial cell can have serious implications for generation of resistance to drugs targeting the respective enzymes. Resistance can simply be achieved through a gene dosage effect or by mutations in which one copy of the gene encodes an enzyme resistant to the antibiotic while the other one continues to function normally. We therefore compared the actinonin-resistance frequency of B. subtilis strains carrying only one def-like gene (MHD101 and MHY101) to that of B. subtilis 168. Remarkably, actinonin resistance arose in each strain at approximately the same frequency of 10 −& . (The frequencies for each strain were determined twice.) One reason for this phenomenon could be that alterations in the fmt genes are the favoured resistance mechanisms even in organisms with two functional deformylases. The lack of formylation makes deformylation dispensable for the cell. This mode of resistance has been described in S. aureus, which harbours only one functional deformylase (Margolis et al., 2000) . Sequence analyses of the relevant chromosomal loci in the resistant B. subtilis strains will be necessary to confirm the hypothesis.
Conclusions
From the evolutionary point of view, two classes of deformylases evolved which possess distant sequence similarity to each other, but which retain similarity in the essential sequence motifs (Fig. 1) and in 3-D structure (Dardel et al., 1998) . Comparison of the two deformylases from B. subtilis illustrates that they possess remarkably similar enzymic properties and can be targeted by the antibiotic actinonin with the same efficiency. Actinonin indeed harbours antibacterial activity against a broad spectrum of bacteria which contain either class I or class II deformylases. B. subtilis is the first organism where expression and functionality of both def-like genes has been demonstrated. Although each of the two genes individually retains viability of B. subtilis, the gene product YkrB probably represents the predominant deformylase species in the organism. The presence of two deformylases in the cell does not necessarily increase the resistance frequency to antibiotics targeting peptide deformylation, such as actinonin. As in other organisms, resistance mechanisms not directly connected to the target also seem to be favoured in B. subtilis.
